Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of joining the study
- People being treated for hormone-dependent localised breast cancer who require additional hormone therapy using a medicine called tamoxifen
- People who have been taking tamoxifen for between 1 and 3 years at most
- People who are enrolled in the French Social Security system
- People who have signed a consent form before joining the study and before any study-related procedures take place
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People whose psychological, family, geographical, or social circumstances would make it difficult to follow the medical check-ups or procedures required by the study
- People who are under legal supervision, such as being under guardianship, curatorship, or court protection, or whose freedom has been restricted by an administrative or legal decision
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 05 31 15 51 04
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of patients who adhere to tamoxifen treatment.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.